If you want to understand how a person is ageing biologically, look at the eye.
Not in a metaphorical sense. Literally, anatomically, clinically — the periorbital region is where the consequences of systemic and dermal biological ageing converge first, and most visibly. It is the face's earliest signal board. A skilled clinician reading the periorbital anatomy — the quality of the lid skin, the position of the fat compartments, the depth of the tear trough, the condition of the orbicularis oculi — is reading a detailed account of decades of biological events.
Understanding why requires a brief orientation to periorbital anatomy, and to the specific mechanisms that alter it over time.
The Anatomy of a Uniquely Vulnerable Region
The skin of the eyelid is the thinnest skin on the body — typically 0.5mm, compared to 2mm or more on the cheek. The dermis beneath it contains fewer sebaceous glands, less subcutaneous fat for insulation, and a relatively sparse Extra Cellular Matrix (ECM) scaffold compared to thicker facial skin. This makes it extraordinarily sensitive to any biological pressure that compromises dermal integrity.
Beneath the skin, the orbicularis oculi muscle encircles the eye. Beneath that, the orbital septum — a fibrous membrane — separates the orbital contents (including the fat pads behind the eye) from the anterior structures. Supporting the lower lid are the retaining ligaments of the face, which anchor the skin and subcutaneous tissue to the underlying skeletal architecture.
All of these structures age. None of them do so simply.
The Five Mechanisms of Periorbital Ageing
Dermal thinning: As Matrix Metalloproteinase (MMP) cascade activity and declining fibroblast function progressively reduce collagen density, the eyelid skin becomes increasingly translucent. This allows the underlying orbicularis oculi muscle — which is reddish-purple in colour — and the superficial vasculature to become visible through the skin as dark circles and blue-grey discolouration. This is not pigmentation. It is structural transparency.
Orbital fat redistribution: Contrary to the common belief that periorbital fullness results from fat accumulation, the primary mechanism is redistribution and herniation. The orbital fat pads — discrete compartments of fat enclosed within fibrous septa behind the orbital septum — do not simply enlarge. Rather, as the orbital septum and retaining ligaments weaken, these fat pads migrate anteriorly, creating the fixed structural fullness of lower lid bags. Simultaneously, fat volume is lost in other zones — particularly the sub-orbicularis oculi fat (SOOF) and the malar fat pad — creating the hollow tear trough and the flattened midface that characterises periorbital ageing.
Retaining ligament laxity: The orbicularis retaining ligament and the orbital retaining ligament anchor the lower lid to the underlying bone. As these ligaments lengthen and weaken, the lower lid descends, the fat pads herniate forward, and the tear trough deepens. This is a structural event — a skeletal and ligamentous change that no topical agent can address.
Lymphatic insufficiency: The periorbital region is drained by a lymphatic network that diminishes in function with age and is highly sensitive to systemic factors including sleep quality, hydration, inflammation, and gravitational position. Reduced lymphatic drainage produces the intermittent fluid accumulation — puffiness — that fluctuates day to day and is particularly pronounced after poor sleep or high salt intake.
Levator aponeurosis descent: The levator palpebrae superioris — the muscle responsible for elevating the upper lid — is attached to the tarsal plate of the upper lid via the levator aponeurosis. Over time, this fibrous attachment can stretch or partially disinherit, causing the upper lid to descend. This is ptosis — true lid descent — and it is a structural functional issue, not simply a cosmetic one. It reduces the visual field, creates chronic brow elevation as a compensatory mechanism, and contributes to the hooded, heavy appearance of the upper periorbital region.
When Surgery Is the Right Answer
Non-surgical protocols — topical actives, growth factor treatments, filler, neuromodulators — can address several periorbital concerns effectively. Skin quality, lymphatic function, and early volume changes respond well to precision non-surgical approaches. The SKNCODE™ protocol for periorbital concerns is specifically designed to address the biological drivers at the dermal and lymphatic level.
But there is a category of periorbital change that non-surgical approaches cannot structurally correct. Herniated orbital fat that has migrated anteriorly through a weakened orbital septum does not respond to topical treatment. Retaining ligament laxity producing lid descent does not respond to filler. True levator aponeurosis ptosis affecting visual field requires surgical correction.
Upper and lower blepharoplasty — performed with an understanding of the specific structural anatomy driving each individual's presentation — addresses these changes at the level of the mechanism. Not by removing tissue indiscriminately, but by restoring the structural relationships that time and biology have altered.
The periorbital region deserves a level of analytical precision that matches its biological complexity. It is not simply the area around the eye. It is one of the most diagnostically rich, structurally sophisticated, and biologically sensitive regions on the human face. Reading it carefully changes everything that follows.